Correction: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review.

Fernández-de-Las-Peñas, César; Torres-Macho, Juan; Catahay, Jesus Alfonso; Macasaet, Raymart; Velasco, Jacqueline Veronica; Macapagal, Sharina; Caldararo, Mario; Henry, Brandon Michael; Lippi, Giuseppe; Franco-Moreno, Ana; Notarte, Kin Israel.

Affiliation

Fernández-de-Las-Peñas C; Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Universidad Rey Juan Carlos, Avenida de Atenas S/N, 28922, Alcorcón, Madrid, Spain. cesar.fernandez@urjc.es.
Torres-Macho J; Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de La Torre, Madrid, Spain.
Catahay JA; Department of Medicine, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
Macasaet R; Department of Medicine, Saint Peter's University Hospital, New Brunswick, NJ, USA.
Velasco JV; Department of Medicine, Monmouth Medical Center, Long Branch, NJ, USA.
Macapagal S; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Caldararo M; Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, USA.
Henry BM; Department of Medicine, Saint Peter's University Hospital, New Brunswick, NJ, USA.
Lippi G; Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Franco-Moreno A; Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
Notarte KI; Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de La Torre, Madrid, Spain.

Infection ; 52(5): 1687, 2024 Oct.

Article in En | MEDLINE | ID: mdl-38451416

Full text: 1 Database: MEDLINE Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Language: En Year: 2024 Type: Article